Results of phase I-II trial of concomitant hyperfractionated radiation and oral etoposide (VP-16) in patients with unresectable squamous cell carcinoma of the head and neck-Reference-Cited by-同舟云学术

Results of phase I-II trial of concomitant hyperfractionated radiation and oral etoposide (VP-16) in patients with unresectable squamous cell carcinoma of the head and neck

Published:2003-01 Issue:1 Volume:24 Page:1-5
ISSN:0196-0709
Container-title:American Journal of Otolaryngology
language:en
Short-container-title:American Journal of Otolaryngology

Author:

Khafif Avi,Canfield Vikki A.,Syzek Elizabeth J.,Medina Jesus E.

Publisher

Elsevier BV

Subject

Otorhinolaryngology

Reference22 articles.

1. Comparison of methotrexate and cisplatin for patients with advanced squamous cell carcinoma of the head and neck region: A Southwest Oncology Group Study;Gross;Cancer Treat Rep,1985

2. The chemotherapy of head and neck cancer;Carter;Semin Oncol,1977

3. Phase II evaluation of bleomycin: A Southwest Oncology Group Study;Hass;Cancer,1976

4. Successful treatment of resistant germinal neoplasms with VP-16 abd cisplatin: Results of Southwestern Cancer Study Group trial;Hainsworth;G Clin Oncol,1985

5. VP-16 and cisplatin as first-line therapy of small cell lung cancer;Evans;J Clin Oncol,1985

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The antitumor drug F14512 enhances cisplatin and ionizing radiation effects in head and neck squamous carcinoma cell lines;Oral Oncology;2014-02

2. Phase I trial of oral etoposide in combination with radiotherapy in head and neck squamous cell carcinoma - GORTEC 2004–02;Radiation Oncology;2013-02-27

3. Topoisomerase expression in oral squamous cell carcinoma: relationship with cancer stem cells profiles and lymph node metastasis;Journal of Oral Pathology & Medicine;2012-06-05

4. Chimiothérapie métronomique en 2011 : actualités et perspectives;Bulletin du Cancer;2011-12

5. Enhanced Antitumor Efficacy of Low-Dose Etoposide with Oncolytic Herpes Simplex Virus in Human Glioblastoma Stem Cell Xenografts;Clinical Cancer Research;2011-10-05